Hypoxia in the bone marrow plays a role in AML blast chemoresistance, and as a result, it can activate NF-kB, which regulates essential pathways such as cell proliferation, metastasis, angiogenesis and survival. This evidence concerns the gene NFKB1 and acute myeloid leukemia.